Rexulti

Lundbeck ups guidance on higher expectations for Rexulti, Vyepti
First Word Pharma
Tue, 08/20/24 - 11:50 am
Lundbeck
earnings
Rexulti
Vyepti
Lundbeck leaves Trintellix to partner Takeda in the US, opting for royalties as it focuses efforts on Rexulti
Fierce Pharma
Wed, 07/31/24 - 11:16 pm
Lundbeck
Takeda
Trintellix
antidepressants
Rexulti
Lundbeck CEO eyes deals to bolster pipeline, complement growth drivers ahead of patent losses
Fierce Pharma
Tue, 01/23/24 - 11:08 am
Lundbeck
Charl van Zyl
Pharma CEOs
Vyepti
Rexulti
FDA rules Otsuka marketing claim overstates Rexulti efficacy, threatening cornerstone of huge TV push
Fierce Pharma
Tue, 11/14/23 - 11:19 am
Otsuka
FDA
Rexulti
pharma marketing
clinical depression
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
Yahoo/Benzinga
Thu, 05/11/23 - 08:53 pm
Otsuka
Lundbeck
FDA
Rexulti
Alzheimer's agitation
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation
Fierce Pharma
Sun, 04/16/23 - 11:17 pm
Lundbeck
Otsuka
Rexulti
Alzheimer's disease
FDA
Otsuka, Lundbeck eye Alzheimer's indication in FDA adcomm for Rexulti label expansion
Endpoints
Thu, 03/30/23 - 10:02 am
Otsuka
Lundbeck
Alzheimer's disease
FDA
Rexulti
Alzheimer's disease agitation
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
FDA approves Otsuka and Lundbeck's schizophrenia treatment
Yahoo/Reuters
Fri, 07/10/15 - 10:53 pm
FDA
Otsuka
Lundbeck
schizophrenia
Rexulti
antipsychotics